Bank Of Montreal »

Summit Therapeutics shares owned by Bank Of Montreal

Quarter-by-quarter ownership of Summit Therapeutics (SMMT) shares owned by Bank Of Montreal from 13F filings

Historical chart of Bank Of Montreal investment in Summit Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Summit Therapeutics held by Bank Of Montreal consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Summit Therapeutics by Bank Of Montreal

Quarter filed Position value Share count Share price at filing
2023-12-31 $75k 26k 2.84
2022-09-30 $35k 29k 1.23

More positions owned by Bank Of Montreal

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Apple (AAPL)
Tesla Motors (TSLA)
Rbc Cad (RY)
Microsoft Corporation (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Toronto Dominion Bk Ont Com New (TD)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Bk Nova Cad (BNS)
Meta Platforms Cl A (META)
Cibc Cad (CM)
Bank Of Montreal Cadcom (BMO)
Walt Disney Company (DIS)

View all positions for Bank Of Montreal

Top funds holding Summit Therapeutics

Vanguard Group
Charles Schwab Investment Management
Steward Partners Investment Advisory
ALPS Advisors
Barclays
Bank of New York Mellon
Jpmorgan Chase & Co
Swiss National Bank
Goldman Sachs Group
UBS Group
Advisor Group Holdings
China Universal Asset Management
Rhumbline Advisers
CSS
Bank of America Corporation

View all funds holding Summit Therapeutics